Brief: Enorama Pharma Carries Out Directed Issue Of About SEK 15 Million
Aug 14 (Reuters) - Enorama Pharma AB ERMA.ST :
* SAID ON TUESDAY HAS DECIDED TO CARRY OUT DIRECTED SHARE
ISSUE OF
ABOUT SEK 15.0 MILLION
* DIRECTED ISSUE OF 232,919 SHARES AT SUBSCRIPTION PRICE OF
SEK
64.4 PER SHARE
* DIRECTED ISSUE WILL RESULT IN DILUTION OF 4.21% IN NUMBER
OF
SHARES AND VOTES IN ENORAMA PHARMA
Source text for Eikon: urn:newsml:reuters.com:*:nWkr1BhR1m
Further company coverage: ERMA.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO